speb/financial-data huggingface dataset:
HRTX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 8457000.00
HRTX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 551000.00
HRTX income_statement (quarterly, 2025-03-31) — Research And Development: 2279000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1916959000.00
HRTX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 25242000.00
HRTX cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 42000.00
HRTX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 12311000.00
HRTX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 25013000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Share Issued: 152427000.00
HRTX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2511000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -28453000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -28453000.00
HRTX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
HRTX balance_sheet (quarterly, 2025-03-31) — Total Assets: 235752000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 146513000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Total Debt: 177256000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -28453000.00
HRTX income_statement (quarterly, 2025-03-31) — Total Expenses: 35749000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 264205000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 22911000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 175648000.00
HRTX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 3154000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Work In Process: 28953000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Working Capital: 124284000.00
HRTX income_statement (quarterly, 2025-06-30) — +Operating Expense: 28980000.00
HRTX income_statement (quarterly, 2025-06-30) — +Total Revenue: 37200000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 12037000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 79931000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1890550000.00
HRTX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -239000.00
HRTX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 154020000.00
HRTX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.02
HRTX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 19269000.00
HRTX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -208000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1539000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1533000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 16516000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 40633000.00
HRTX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 781000.00
HRTX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 7334000.00
HRTX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -10868000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -296000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -3769000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Inventory: -16033000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Payable: -296000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -4065000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 9302000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1195000.00
HRTX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -11991000.00
HRTX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1195000.00
HRTX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2753000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Common Stock: 1533000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -27258000.00
HRTX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 9857000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 69821000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Current Assets: 210923000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1539000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Current Debt: 175204000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 176743000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 258601000.00
HRTX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 611000.00
HRTX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 611000.00
HRTX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 154020000.00
HRTX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.02
HRTX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2381000.00
HRTX income_statement (quarterly, 2025-06-30) — EBIT: -1637000.00
HRTX income_statement (quarterly, 2025-06-30) — EBITDA: -1026000.00
HRTX cash_flow (quarterly, 2025-06-30) — End Cash Position: 16516000.00
HRTX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 781000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 11003000.00
HRTX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -11076000.00
HRTX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 129000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1000.00
HRTX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 14471000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 15084000.00
HRTX income_statement (quarterly, 2025-06-30) — Gross Profit: 27343000.00
HRTX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 1776000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Inventory: 72965000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 147946000.00
HRTX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 7334000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Net Debt: 158688000.00
HRTX income_statement (quarterly, 2025-06-30) — Net Income: -2381000.00
HRTX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2381000.00
HRTX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2381000.00
HRTX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2381000.00
HRTX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2381000.00
HRTX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2381000.00
HRTX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2381000.00
HRTX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 7531000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Net PPE: 15084000.00
HRTX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -197000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -27258000.00
HRTX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1026000.00
HRTX income_statement (quarterly, 2025-06-30) — Normalized Income: -2381000.00
HRTX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -10868000.00
HRTX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 129000.00
HRTX income_statement (quarterly, 2025-06-30) — Operating Income: -1637000.00
HRTX income_statement (quarterly, 2025-06-30) — Operating Revenue: 37200000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 153252956.00
HRTX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 17394000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 175204000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1000.00
HRTX income_statement (quarterly, 2025-06-30) — Other Gand A: 14471000.00
HRTX income_statement (quarterly, 2025-06-30) — Other Income Expense: -744000.00
HRTX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 206000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 6083000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 747000.00
HRTX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -744000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Other Properties: 15084000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 24117000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Payables: 12037000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 81858000.00
HRTX income_statement (quarterly, 2025-06-30) — Pretax Income: -2381000.00
HRTX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -9185000.00
HRTX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -208000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 35817000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Receivables: 79931000.00
HRTX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 9857000.00
HRTX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 611000.00
HRTX income_statement (quarterly, 2025-06-30) — Research And Development: 2934000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1919340000.00
HRTX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 16716000.00
HRTX cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 11000.00
HRTX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 11575000.00
HRTX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 26046000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Share Issued: 153252956.00
HRTX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2797000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -27258000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -27258000.00
HRTX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
HRTX balance_sheet (quarterly, 2025-06-30) — Total Assets: 232090000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -27258000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Total Debt: 176743000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -27258000.00
HRTX income_statement (quarterly, 2025-06-30) — Total Expenses: 38837000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 259348000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 21167000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 747000.00
HRTX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1637000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Work In Process: 26145000.00
HRTX balance_sheet (quarterly, 2025-06-30) — Working Capital: -47678000.00
HRTX income_statement (quarterly, 2025-09-30) — +Operating Expense: 30392000.00
HRTX income_statement (quarterly, 2025-09-30) — +Total Revenue: 38213000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 12017000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 81047000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1942025000.00
HRTX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -130000.00
HRTX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 170348000.00
HRTX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.10
HRTX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 16516000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 780000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 9695000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 43068000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 55487000.00
HRTX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 13363000.00
HRTX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 11858000.00
HRTX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1331000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -20000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 7084000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Inventory: 2940000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Payable: -20000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 7064000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -5248000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1116000.00
HRTX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3640000.00
HRTX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1116000.00
HRTX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 26552000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Common Stock: 1833000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 7023000.00
HRTX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 11914000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 76911000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Current Assets: 229400000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 780000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 780000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 89708000.00
HRTX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 615000.00
HRTX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 615000.00
HRTX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 170348000.00
HRTX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.10
HRTX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -17495000.00
HRTX income_statement (quarterly, 2025-09-30) — EBIT: -4093000.00
HRTX income_statement (quarterly, 2025-09-30) — EBITDA: -3478000.00
HRTX cash_flow (quarterly, 2025-09-30) — End Cash Position: 43068000.00
HRTX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 13363000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Finished Goods: 10897000.00
HRTX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 1331000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 0.00
HRTX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 13980000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 13668000.00
HRTX income_statement (quarterly, 2025-09-30) — Gross Profit: 26299000.00
HRTX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1450000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Inventory: 70025000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 146686000.00
HRTX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 11858000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 139663000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 139663000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Net Debt: 96595000.00
HRTX income_statement (quarterly, 2025-09-30) — Net Income: -17495000.00
HRTX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -17495000.00
HRTX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -17495000.00
HRTX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -17495000.00
HRTX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -17495000.00
HRTX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -17495000.00
HRTX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -17495000.00
HRTX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 11829000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Net PPE: 13668000.00
HRTX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 29000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 14885000.00
HRTX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 7861000.00
HRTX income_statement (quarterly, 2025-09-30) — Normalized Income: -6156000.00
HRTX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1331000.00
HRTX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 11244000.00
HRTX income_statement (quarterly, 2025-09-30) — Operating Income: -4093000.00
HRTX income_statement (quarterly, 2025-09-30) — Operating Revenue: 38213000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 183324000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 22841000.00
HRTX income_statement (quarterly, 2025-09-30) — Other Gand A: 13980000.00
HRTX income_statement (quarterly, 2025-09-30) — Other Income Expense: -13402000.00
HRTX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 196000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5882000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4694000.00
HRTX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -2063000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Other Properties: 13668000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 12419000.00
HRTX income_statement (quarterly, 2025-09-30) — Other Special Charges: 11339000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Payables: 12017000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 88928000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 7862000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 7862000.00
HRTX income_statement (quarterly, 2025-09-30) — Pretax Income: -17495000.00
HRTX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -51000.00
HRTX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -6127000.00
HRTX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
HRTX balance_sheet (quarterly, 2025-09-30) — Raw Materials: 32785000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Receivables: 81047000.00
HRTX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 11914000.00
HRTX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 615000.00
HRTX income_statement (quarterly, 2025-09-30) — Research And Development: 3470000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1936835000.00
HRTX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 17956000.00
HRTX cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 29000.00
HRTX income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 12942000.00
HRTX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 26922000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Share Issued: 183324000.00
HRTX income_statement (quarterly, 2025-09-30) — Special Income Charges: -11339000.00
HRTX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2852000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 14885000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 7023000.00
HRTX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
HRTX balance_sheet (quarterly, 2025-09-30) — Total Assets: 248950000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 154548000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Total Debt: 140443000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 14885000.00
HRTX income_statement (quarterly, 2025-09-30) — Total Expenses: 42306000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 234065000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 19550000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 144357000.00
HRTX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4093000.00
HRTX income_statement (quarterly, 2025-09-30) — Total Unusual Items: -11339000.00
HRTX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -11339000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Work In Process: 26343000.00
HRTX balance_sheet (quarterly, 2025-09-30) — Working Capital: 139692000.00
HRTX income_statement (annual, 2025-12-31) — +Operating Expense: 116095000.00
HRTX income_statement (quarterly, 2025-12-31) — +Operating Expense: 29431000.00
HRTX income_statement (annual, 2025-12-31) — +Total Revenue: 154904000.00
HRTX income_statement (quarterly, 2025-12-31) — +Total Revenue: 40588000.00
HRTX balance_sheet (annual, 2025-12-31) — Accounts Payable: 8994000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 8994000.00
HRTX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 89587000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 89587000.00
HRTX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -12880000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -12880000.00
HRTX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1951185000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1951185000.00
HRTX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -739000.00
HRTX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -89000.00
HRTX income_statement (annual, 2025-12-31) — Basic Average Shares: 166707000.00
HRTX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 188031000.00
HRTX income_statement (annual, 2025-12-31) — Basic EPS: -0.12
HRTX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.02
HRTX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 25802000.00
HRTX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 43068000.00
HRTX cash_flow (annual, 2025-12-31) — Capital Expenditure: -317000.00
HRTX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
HRTX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Capital Stock: 2933000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2933000.00
HRTX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 28647000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 28647000.00
HRTX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 46631000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 46631000.00
HRTX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 14427000.00
HRTX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 219000.00
HRTX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 16009000.00
HRTX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5456000.00
HRTX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -27591000.00
HRTX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -9184000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Account Payable: -2715000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -3023000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 11715000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 11256000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Inventory: -31052000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -14187000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Payable: -2715000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Payable: -3023000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 9000000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 8233000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 878000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 5428000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Receivables: -10706000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -8540000.00
HRTX cash_flow (annual, 2025-12-31) — Change In Working Capital: -31880000.00
HRTX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -9066000.00
HRTX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -10706000.00
HRTX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -8540000.00
HRTX cash_flow (annual, 2025-12-31) — Changes In Cash: 2845000.00
HRTX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -14421000.00
HRTX balance_sheet (annual, 2025-12-31) — Common Stock: 1883000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Common Stock: 1883000.00
HRTX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 13283000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 13283000.00
HRTX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 18307000.00
HRTX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: -1531000.00
HRTX income_statement (annual, 2025-12-31) — Cost Of Revenue: 41347000.00
HRTX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11119000.00
HRTX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 78490000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 78490000.00
HRTX balance_sheet (annual, 2025-12-31) — Current Assets: 238066000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Current Assets: 238066000.00
HRTX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
HRTX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Current Liabilities: 96098000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 96098000.00
HRTX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2314000.00
HRTX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 537000.00
HRTX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2314000.00
HRTX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 537000.00
HRTX income_statement (annual, 2025-12-31) — Diluted Average Shares: 166707000.00
HRTX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 188031000.00
HRTX income_statement (annual, 2025-12-31) — Diluted EPS: -0.12
HRTX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.02
HRTX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2954000.00
HRTX income_statement (annual, 2025-12-31) — EBIT: -10590000.00
HRTX income_statement (quarterly, 2025-12-31) — EBIT: -8014000.00
HRTX income_statement (annual, 2025-12-31) — EBITDA: -8276000.00
HRTX income_statement (quarterly, 2025-12-31) — EBITDA: -7477000.00
HRTX cash_flow (annual, 2025-12-31) — End Cash Position: 28647000.00
HRTX cash_flow (quarterly, 2025-12-31) — End Cash Position: 28647000.00
HRTX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 14427000.00
HRTX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 219000.00
HRTX balance_sheet (annual, 2025-12-31) — Finished Goods: 6883000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 6883000.00
HRTX cash_flow (annual, 2025-12-31) — Free Cash Flow: -27908000.00
HRTX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -9184000.00
HRTX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 414000.00
HRTX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4000.00
HRTX income_statement (annual, 2025-12-31) — General And Administrative Expense: 54605000.00
HRTX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 13452000.00
HRTX balance_sheet (annual, 2025-12-31) — Gross PPE: 25283000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 25283000.00
HRTX income_statement (annual, 2025-12-31) — Gross Profit: 113557000.00
HRTX income_statement (quarterly, 2025-12-31) — Gross Profit: 29469000.00
HRTX income_statement (annual, 2025-12-31) — Interest Expense: 9605000.00
HRTX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 9605000.00
HRTX income_statement (annual, 2025-12-31) — Interest Income: 1948000.00
HRTX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1948000.00
HRTX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 6512000.00
HRTX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 2650000.00
HRTX balance_sheet (annual, 2025-12-31) — Interest Payable: 904000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Interest Payable: 904000.00
HRTX balance_sheet (annual, 2025-12-31) — Inventory: 92746000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Inventory: 92746000.00
HRTX balance_sheet (annual, 2025-12-31) — Invested Capital: 153921000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 153921000.00
HRTX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 16009000.00
HRTX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -5456000.00
HRTX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 26169000.00
HRTX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: -1531000.00
HRTX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 137245000.00
HRTX cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -4792000.00
HRTX balance_sheet (annual, 2025-12-31) — Leases: 0.00
HRTX balance_sheet (quarterly, 2025-12-31) — Leases: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Long Term Debt: 140638000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 140638000.00
HRTX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 140638000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 140638000.00
HRTX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 137245000.00
HRTX cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -4792000.00
HRTX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -150000000.00
HRTX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 194000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 194000.00
HRTX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 18307000.00
HRTX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1531000.00
HRTX balance_sheet (annual, 2025-12-31) — Net Debt: 111991000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Net Debt: 111991000.00
HRTX income_statement (annual, 2025-12-31) — Net Income: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Net Income: -2954000.00
HRTX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2954000.00
HRTX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2954000.00
HRTX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2954000.00
HRTX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2954000.00
HRTX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -20195000.00
HRTX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2954000.00
HRTX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2954000.00
HRTX income_statement (annual, 2025-12-31) — Net Interest Income: -7657000.00
HRTX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 16228000.00
HRTX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -5472000.00
HRTX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -12755000.00
HRTX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -4792000.00
HRTX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -12755000.00
HRTX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -4792000.00
HRTX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -7657000.00
HRTX balance_sheet (annual, 2025-12-31) — Net PPE: 12403000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Net PPE: 12403000.00
HRTX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -219000.00
HRTX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 16000.00
HRTX cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 7862000.00
HRTX cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 14333000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 14333000.00
HRTX income_statement (annual, 2025-12-31) — Normalized EBITDA: 3063000.00
HRTX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -7477000.00
HRTX income_statement (annual, 2025-12-31) — Normalized Income: -8856000.00
HRTX income_statement (quarterly, 2025-12-31) — Normalized Income: -2954000.00
HRTX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -27591000.00
HRTX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -9184000.00
HRTX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 11753000.00
HRTX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 414000.00
HRTX income_statement (annual, 2025-12-31) — Operating Income: -2538000.00
HRTX income_statement (quarterly, 2025-12-31) — Operating Income: 38000.00
HRTX income_statement (annual, 2025-12-31) — Operating Revenue: 154904000.00
HRTX income_statement (quarterly, 2025-12-31) — Operating Revenue: 40588000.00
HRTX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 188314430.00
HRTX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 188314430.00
HRTX balance_sheet (annual, 2025-12-31) — Other Current Assets: 9102000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 9102000.00
HRTX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 4000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 4000.00
HRTX income_statement (annual, 2025-12-31) — Other Gand A: 54605000.00
HRTX income_statement (quarterly, 2025-12-31) — Other Gand A: 13452000.00
HRTX income_statement (annual, 2025-12-31) — Other Income Expense: -10000000.00
HRTX income_statement (quarterly, 2025-12-31) — Other Income Expense: 4665000.00
HRTX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 817000.00
HRTX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 204000.00
HRTX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 5408000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 5408000.00
HRTX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 4808000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4808000.00
HRTX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1339000.00
HRTX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 4665000.00
HRTX balance_sheet (annual, 2025-12-31) — Other Properties: 25089000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Other Properties: 25089000.00
HRTX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 17984000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 17984000.00
HRTX income_statement (annual, 2025-12-31) — Other Special Charges: 11339000.00
HRTX income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Payables: 8994000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Payables: 8994000.00
HRTX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 87484000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 87484000.00
HRTX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8614000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8614000.00
HRTX balance_sheet (annual, 2025-12-31) — Preferred Stock: 1050000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1050000.00
HRTX balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1050000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1050000.00
HRTX cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 7862000.00
HRTX cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
HRTX income_statement (annual, 2025-12-31) — Pretax Income: -20195000.00
HRTX income_statement (quarterly, 2025-12-31) — Pretax Income: -2954000.00
HRTX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1013000.00
HRTX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 219000.00
HRTX balance_sheet (annual, 2025-12-31) — Properties: 0.00
HRTX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HRTX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -50786000.00
HRTX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -12572000.00
HRTX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -317000.00
HRTX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Raw Materials: 59250000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 59250000.00
HRTX balance_sheet (annual, 2025-12-31) — Receivables: 89587000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Receivables: 89587000.00
HRTX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 41347000.00
HRTX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11119000.00
HRTX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2314000.00
HRTX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 537000.00
HRTX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -150000000.00
HRTX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
HRTX income_statement (annual, 2025-12-31) — Research And Development: 12429000.00
HRTX income_statement (quarterly, 2025-12-31) — Research And Development: 3746000.00
HRTX balance_sheet (annual, 2025-12-31) — Retained Earnings: -1939789000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1939789000.00
HRTX cash_flow (annual, 2025-12-31) — Sale Of Investment: 67014000.00
HRTX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 7100000.00
HRTX cash_flow (annual, 2025-12-31) — Sale Of PPE: 98000.00
HRTX cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 16000.00
HRTX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 49061000.00
HRTX income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 12233000.00
HRTX income_statement (annual, 2025-12-31) — Selling General And Administration: 103666000.00
HRTX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 25685000.00
HRTX balance_sheet (annual, 2025-12-31) — Share Issued: 188314430.00
HRTX balance_sheet (quarterly, 2025-12-31) — Share Issued: 188314430.00
HRTX income_statement (annual, 2025-12-31) — Special Income Charges: -11339000.00
HRTX income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
HRTX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 10339000.00
HRTX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2179000.00
HRTX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 14333000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 14333000.00
HRTX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 13283000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 13283000.00
HRTX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
HRTX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Total Assets: 255877000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Total Assets: 255877000.00
HRTX balance_sheet (annual, 2025-12-31) — Total Capitalization: 154971000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 154971000.00
HRTX balance_sheet (annual, 2025-12-31) — Total Debt: 140638000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Total Debt: 140638000.00
HRTX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 14333000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 14333000.00
HRTX income_statement (annual, 2025-12-31) — Total Expenses: 157442000.00
HRTX income_statement (quarterly, 2025-12-31) — Total Expenses: 40550000.00
HRTX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 241544000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 241544000.00
HRTX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 17811000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 17811000.00
HRTX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 145446000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 145446000.00
HRTX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2538000.00
HRTX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 38000.00
HRTX income_statement (annual, 2025-12-31) — Total Unusual Items: -11339000.00
HRTX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
HRTX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -11339000.00
HRTX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
HRTX balance_sheet (annual, 2025-12-31) — Work In Process: 26613000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Work In Process: 26613000.00
HRTX balance_sheet (annual, 2025-12-31) — Working Capital: 141968000.00
HRTX balance_sheet (quarterly, 2025-12-31) — Working Capital: 141968000.00
HRTX income_statement (quarterly, 2026-03-31) — +Operating Expense: 28838000.00
HRTX income_statement (quarterly, 2026-03-31) — +Total Revenue: 34711000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8970000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 83693000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1954107000.00
HRTX cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -144000.00
HRTX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 189646000.00
HRTX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.04
HRTX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 28647000.00
HRTX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -391000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2936000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 26117000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 44784000.00
HRTX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -51000.00
HRTX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -939000.00
HRTX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1540000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -24000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -3840000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -169000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Payable: -24000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3864000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 1122000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Receivables: 5894000.00
HRTX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2983000.00
HRTX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 5894000.00
HRTX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2530000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Common Stock: 1886000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 8087000.00
HRTX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -51000.00
HRTX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10638000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 81546000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Current Assets: 228984000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 90516000.00
HRTX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 529000.00
HRTX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 529000.00
HRTX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 189646000.00
HRTX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.04
HRTX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -8111000.00
HRTX income_statement (quarterly, 2026-03-31) — EBIT: -4765000.00
HRTX income_statement (quarterly, 2026-03-31) — EBITDA: -4236000.00
HRTX cash_flow (quarterly, 2026-03-31) — End Cash Position: 26117000.00
HRTX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -51000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Finished Goods: 10359000.00
HRTX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1931000.00
HRTX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 7000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -6000.00
HRTX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 12145000.00
HRTX income_statement (quarterly, 2026-03-31) — Gross Profit: 24073000.00
HRTX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 2627000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Inventory: 92539000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 149721000.00
HRTX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -939000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 141634000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 141634000.00
HRTX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -51000.00
HRTX balance_sheet (quarterly, 2026-03-31) — Net Debt: 115517000.00
HRTX income_statement (quarterly, 2026-03-31) — Net Income: -8111000.00
HRTX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -8111000.00
HRTX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -8111000.00